Laila Tablets Private Limited
About Laila Tablets Private Limited
Data last updated:
Laila Tablets Private Limited is a private limited company based in Vijayawada, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 December 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24232AP2007PTC056590.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rathi Devi Gokaraju and Ganga Raju Gokaraju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 40 – 15 – 14 Brindavan Colony Labbipet, Vijayawada, Andhra Pradesh, India – 520010.
As per the financials filed for FY 2025, the company reported a revenue of ₹54,000, a decline of 2% compared to the previous year. Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address40 – 15 – 14 Brindavan Colony Labbipet, Vijayawada, Andhra Pradesh, India – 520010
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Laila Tablets Private Limited FY 2025 filings available
Laila Tablets Private Limited reported revenue of ₹54,000 (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Laila Tablets Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 2% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Laila Tablets Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Laila Tablets Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Laila Tablets are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Laila Tablets Private Limited
Laila Tablets Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medorb Pharmaceutical Private Limited | ₹55,174 (FY 2025) | •••• | •••• | -96.0% | •••• | Jaipur, Rajasthan, India |
| Sierra Indchem Private Limited | ₹55,063 (FY 2021) | •••• | •••• | •••• | Mumbra, Maharashtra, India | |
| Asuma Research Ltd | ₹55,000 (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Bioamvil Laboratories Private Limited | ₹54,659 (FY 2024) | •••• | •••• | 70.0% | •••• | Udaipur, Rajasthan, India |
| Kiyaan Pharmaceuticals Private Limited | ₹54,579 (FY 2025) | •••• | •••• | -86.0% | •••• | Aurangabad, Maharashtra, India |
| Laila Tablets Private Limited this company | ₹54,000 (FY 2025) | •••• | •••• | -2.0% | •••• | Vijayawada, Andhra Pradesh, India |
| Nirkon Industries Private Ltd | ₹53,660 (FY 2025) | •••• | •••• | -93.0% | •••• | Kolkata, West Bengal, India |
| Codon Pharma Private Limited | ₹52,880 (FY 2025) | •••• | •••• | -95.0% | •••• | Noida, Uttar Pradesh, India |
| Joshi Pharmaceutical Industries Private Limited | ₹52,861 (FY 2025) | •••• | •••• | -96.0% | •••• | Pune, Maharashtra, India |
| Gajpati Industries Private Limited | ₹52,000 (FY 2024) | •••• | •••• | 63.0% | •••• | Jammu, Jammu and Kashmir, India |
| Ram Lal Laboratories Private Limited | ₹52,000 (FY 2025) | •••• | •••• | 9.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Laila Tablets by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Laila Tablets Private Limited
Auditor information for Laila Tablets Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Board of Directors of Laila Tablets Private Limited
Laila Tablets has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rathi Devi Gokaraju Also directs: Laila Aquatech Limited, Laila Chemicals Private Limited, Laila Formulations Private Limited and 5 more | Director | 10 Aug 2014 | 12 Years 2 Months | Current |
| Ganga Raju Gokaraju Also directs: Laila Aquatech Limited, Icurry Foods Private Limited, Nizam Deccan Sugars Limited and 5 more | Director | 07 Dec 2007 | 18 Years 10 Months | Current |
Ownership and Shareholding of Laila Tablets Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Laila Tablets Private Limited
Laila Tablets Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Laila Tablets Private Limited
Employment history and EPFO contributions of people linked to Laila Tablets.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Laila Tablets Private Limited
Laila Tablets Private Limited has 4 board changes on record since 2007: 3 appointments and 1 cessation. The latest: Rama Raju Gokaraju ceased to be Director on 10 Aug 2014.
Credit Ratings, Litigation & Regulatory Alerts for Laila Tablets Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Laila Tablets Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Laila Tablets Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Laila Tablets Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Laila Tablets Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Laila Tablets Private Limited
Laila Tablets is an active private limited company based in Vijayawada, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 December 2007 (19+ years old) and is registered under CIN U24232AP2007PTC056590.
Laila Tablets reported revenue of ₹54,000 for FY 2025 (down 2% YoY).
Laila Tablets has 2 current directors:
- Rathi Devi Gokaraju - Director
- Ganga Raju Gokaraju - Director
The compounded annual growth rate (CAGR) of the revenue of Laila Tablets is -2% over three years and -1% over five years. In the latest year (FY 2025) revenue fell 2%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Laila Tablets is U24232AP2007PTC056590. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Laila Tablets was incorporated on 07 December 2007, making it 19+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Laila Tablets by revenue are Medorb Pharmaceutical Private Limited, Sierra Indchem Private Limited, Asuma Research Ltd, Bioamvil Laboratories Private Limited, Kiyaan Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Rama Raju Gokaraju ceased to be Director on 10 Aug 2014. Rathi Devi Gokaraju was appointed as Director on 10 Aug 2014. Ganga Raju Gokaraju was appointed as Director on 07 Dec 2007. Laila Tablets has 4 board changes on record in total.
The registered office of Laila Tablets is at 40 – 15 – 14 Brindavan Colony Labbipet, Vijayawada, Andhra Pradesh, India – 520010.
Laila Tablets has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Laila Tablets operates in the pharma industry, in the drug formulation and development segment.